Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.
about
Patterns of colorectal cancer care in the United States and Canada: a systematic reviewColorectal cancer screening and surveillance in the elderly: updates and controversiesDecision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.Optimizing adjuvant therapy and survivorship care of stage III colon cancer.Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancerLimits of observational data in determining outcomes from cancer therapy.Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicityThe effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort studyThe influence of long-term care insurance on the likelihood of nursing home admissionInferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settingsComparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.Radiotherapy Planning Complexity and Survival after Treatment of Advanced Stage Lung Cancer in the ElderlySystemic therapy for elderly patients with gastrointestinal cancer.Completion of therapy by Medicare patients with stage III colon cancer.Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects.Older patients with colon cancer: is adjuvant chemotherapy safe and effective?Predictors of referral for adjuvant therapy for colorectal cancer.Chemotherapy for colorectal cancer in the elderly.The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist.The impact of age on quality measure adherence in colon cancer.Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer.Uptake of oxaliplatin and bevacizumab for treatment of node-positive and metastatic colon cancerA panel discussion of controversies and challenges in the adjuvant treatment of colon cancer.Treatment of elderly cancer patients with chemotherapy.Differences in the therapeutic approach to colorectal cancer in young and elderly patientsCharacteristics affecting survival after locally advanced colorectal cancer in Quebec.Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?Association between the availability of medical oncologists and initiation of chemotherapy for patients with stage III colon cancer.Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients.Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma.Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy.Tolerance to chemotherapy in elderly patients with cancer.Factors Associated With Unplanned Hospitalizations Among Patients With Nonmetastatic Colorectal Cancers Intended for Treatment in the Ambulatory Setting.Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival.Patterns of Treatment Sequences in Chemotherapy and Targeted Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-Based Cohort of Elderly Patients.Patterns of Colorectal Cancer Care in the United States: 1990-2010.
P2860
Q26863029-953DA6F1-DE03-410B-8FAB-3DCABCBB5AC7Q26998578-C30F4C66-5B8E-41C0-B694-F12BF6FAE5D4Q30244769-8123851F-6DBD-46EC-8D53-851CAC8E17D5Q30249616-167053F7-307C-4B0B-94F5-13C130DE3B18Q30418160-A443B06A-589F-48EA-8D14-BBC84F545BA5Q30422446-4990CC7E-6777-4CD9-8B79-363443170BFEQ31153256-4246C2A8-7D68-431D-8764-A18E157D6F39Q33367028-3C99384E-4355-4CA0-B3C1-366E0C330129Q33432354-ACDB8013-955A-4B9A-8E0A-97F068B0E7DDQ33605809-E4718685-1AF7-400E-94A8-6EDE70208231Q33646009-469737D5-685B-40E0-8AC9-F39020D6C321Q33937296-D61847E7-08EB-46E8-9617-0F0A4BA5A7A1Q33946721-D1066059-A771-4671-AB0F-235FEA19957AQ34339987-5837F5AE-4063-4B7D-9BB3-9C0A672C7499Q34567560-E6565EF9-7AA4-4D56-833F-DA0178D7F370Q34680500-581585F1-B204-45E8-BEDD-C5A0E4AB7F12Q34982764-FC00D6EE-8EC1-43FB-B014-A031D43C4447Q35071455-69D434FD-71E5-4CF5-AB1F-CC9505981693Q35076279-D3354BD0-8DD3-45E9-A9AA-809DBEA30B94Q35092149-8EB9B34F-971A-4818-8A50-FAC469A7432EQ35537282-78EA1773-921F-4287-90BE-E0E44004F9C7Q35567604-E6658732-EF86-4C11-A1D3-E406B2BE8080Q35750336-98640BC0-3531-4264-8ECC-CE8AEE757E49Q35792920-D6EC023F-7333-4EF4-BBB3-EBB4A3253851Q35878821-2F2ECD4E-2FC2-4D24-8662-986AC3E01851Q36095157-0D91134C-7528-4F72-A1D8-64733E22F066Q36125075-9C5C5CF5-2AF6-4208-96FD-181A52C698EDQ36276360-B4D29A81-21F8-44BC-81F1-A7451878A667Q36349591-3ED43682-15B3-4A83-AE9D-83B4B51E68FEQ36394634-CABC7213-F1F3-48A8-BD87-539A7FCB38E1Q36503071-4AB47AEE-BB21-469E-AC23-BAEC44AE1859Q36534769-9F7DFE5A-A23F-42C3-8CB5-F02D54697817Q36609950-9EF45E91-5A9F-4598-A0EE-594A81322310Q36648440-2E8D27F3-A9EB-4D49-820A-77D9B41B20A3Q36695795-293EF41C-D219-4DAD-96ED-08B1F1E3D94CQ36715266-D445BF72-97D8-4C82-84C5-C3CD8E1B513BQ36738038-800EF3B0-BBCD-4F72-8DD5-E3E84E52E34EQ36743301-C12D2889-1657-4B95-BC4A-86B7912D0967Q36761488-80889243-C146-44F9-B9B1-8BB4550C4D4EQ36824126-2FBD5F58-9E94-47EB-8BBB-E0D8A7C1CA9B
P2860
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Survival associated with 5-flu ...... th node-positive colon cancer.
@en
Survival associated with 5-flu ...... th node-positive colon cancer.
@nl
type
label
Survival associated with 5-flu ...... th node-positive colon cancer.
@en
Survival associated with 5-flu ...... th node-positive colon cancer.
@nl
prefLabel
Survival associated with 5-flu ...... th node-positive colon cancer.
@en
Survival associated with 5-flu ...... th node-positive colon cancer.
@nl
P2093
P1476
Survival associated with 5-flu ...... th node-positive colon cancer.
@en
P2093
Alfred I Neugut
Daniel F Heitjan
Judith S Jacobson
Nandita Mitra
Victor R Grann
Vijaya Sundararajan
P304
P356
10.7326/0003-4819-136-5-200203050-00007
P407
P577
2002-03-01T00:00:00Z